脳梗塞患者における術前の抗血小板薬休薬に関する検討

DOI 被引用文献1件 参考文献13件

書誌事項

タイトル別名
  • Estimation of the perioperative management of stroke patients receiving antiplatelet therapy

この論文をさがす

抄録

There is no direct evidence as to whether antiplatelet therapy should be discontinued or not when patients with cerebrovascular diseases undergo surgery or invasive examinations. We therefore examined the platelet aggregability as a marker for determining the adequate period to discontinue the antiplatelet agents. 22 patients who underwent surgery or examination were discontinued on antiplatelet agents (9 patients on aspirin and 13 patients on ticlopidine) for 14 days before the operation. The aggregability in the aspirin group was significantly increased on the 3rd day as compared to that before the discontinuance (14.0±8.5% vs. 48.1±31.2%; p<0.05). The aggregability in the ticlopidine group was significantly increased on the 14th day (19.5±11.4% vs. 58.4±30.8%; p<0.05). We conclude that it is desirable to pause aspirin for 3 days and ticlopidine for 2 weeks, in terms of the platelet aggregability.

収録刊行物

  • 脳卒中

    脳卒中 28 (2), 286-290, 2006

    一般社団法人 日本脳卒中学会

被引用文献 (1)*注記

もっと見る

参考文献 (13)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ